loadpatents
name:-0.028753042221069
name:-0.016736030578613
name:-0.0052840709686279
LEVY; Daniel E. Patent Filings

LEVY; Daniel E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEVY; Daniel E..The latest application filed is for "polymorphic form of sepiapterin".

Company Profile
3.10.18
  • LEVY; Daniel E. - San Mateo CA
  • LEVY; Daniel E. - Armadale Victoria
  • Levy; Daniel E. - San Carlos CA
  • Levy; Daniel E. - Alameda CA
  • Levy; Daniel E. - Oakland CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polymorphic Form Of Sepiapterin
App 20220081443 - YOSHINO; Hiroshi ;   et al.
2022-03-17
Method For Preparing And Delivering Bisantrene Formulations
App 20210379021 - LEVY; Daniel E. ;   et al.
2021-12-09
Polymorphs Of Sepiapterin And Salts Thereof
App 20210300930 - LEVY; Daniel E.
2021-09-30
Polymorphic form of sepiapterin
Grant 11,130,760 - Yoshino , et al. September 28, 2
2021-09-28
Pharmaceutically Acceptable Salts Of Sepiapterin
App 20210269443 - LEVY; Daniel E. ;   et al.
2021-09-02
Polymorphs of sepiapterin and salts thereof
Grant 11,072,614 - Levy July 27, 2
2021-07-27
Nanoparticles For Transfection
App 20210180089 - VENABLES; Andrew ;   et al.
2021-06-17
Dicarboxylic Fatty Acid Dimers, And Derivatives Thereof, As Standards For Quantifying Levels In Biospecimens
App 20200199038 - Jayasinghe; Dushmanthi ;   et al.
2020-06-25
Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof
App 20200061070 - LEVY; Daniel E.
2020-02-27
Polymorphic Form Of Sepiapterin
App 20200010469 - YOSHINO; Hiroshi ;   et al.
2020-01-09
Polymorphs Of Sepiapterin And Salts Thereof
App 20190308975 - LEVY; Daniel E.
2019-10-10
Adenylyl cyclase inhibitors, pharmaceutical compositions and method of use thereof
Grant 10,081,633 - Levy , et al. September 25, 2
2018-09-25
CaMKII inhibitors and uses thereof
Grant 9,951,061 - Levy , et al. April 24, 2
2018-04-24
Adenylyl Cyclase Inhibitors, Pharmaceutical Compositions And Method Of Use Thereof
App 20170362235 - Levy; Daniel E. ;   et al.
2017-12-21
C-20 Steroid Compounds, Compositions And Uses Thereof To Treat Traumatic Brain Injury (tbi), Including Concussions
App 20160168190 - Levy; Daniel E.
2016-06-16
Synthesis Of Ent-progesterone And Intermediates Thereof
App 20160108081 - Levy; Daniel E. ;   et al.
2016-04-21
CaMKII INHIBITORS AND USES THEREOF
App 20160024078 - Levy; Daniel E. ;   et al.
2016-01-28
Synthesis Of Ent-progesterone And Intermediates Thereof
App 20150175650 - Levy; Daniel E. ;   et al.
2015-06-25
Heterobifunctional Polyethylene Glycol Reagents
App 20110282093 - Levy; Daniel E. ;   et al.
2011-11-17
Methods and compositions for treating diseases associated with pathogenic proteins
App 20070179123 - Chiang; Peter K. ;   et al.
2007-08-02
4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds
Grant 7,115,741 - Levy , et al. October 3, 2
2006-10-03
Piperazine and homopiperazine compounds
App 20030153556 - Levy, Daniel E. ;   et al.
2003-08-14
Process for preparing synthetic matrix metalloprotease inhibitors
Grant 5,892,112 - Levy , et al.
1999-04-06
Sialyl Lewis.sup.x mimetics containing phenyl backbones
Grant 5,789,385 - Anderson , et al. August 4, 1
1998-08-04
Synthetic matrix metalloprotease inhibitors and use thereof
Grant 5,773,438 - Levy , et al. June 30, 1
1998-06-30
Sialic acid/fucose based medicaments
Grant 5,658,880 - Dasgupta , et al. August 19, 1
1997-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed